Effect of using nifedipine by patients with chronic congestive heart failure treated with digoxin and furosemide

Nifedipine was administrated to 25 patients with chronic congestive heart failure treated with digoxin and furosemide++, nifedipine (NF) in a daily dose of 30-80 mg for 14 days. Before and after the treatment with nifedipine chest X-ray, blood biochemical investigations, echocardiographic evaluation of the left ventricular function and submaximal exercise test were performed. Nifedipine induced significant decreases in the left ventricular systolic dimension, heart volume, blood serum potassium and uric acid concentrations and hematocrit . Resting and exertional heart rate, blood pressure, exercise power and duration, watt-pulse, myocardial oxygen demand index, ejection fraction, cardiac output, body weight, 24-hour urinary output, blood serum concentrations of urea, creatinine, sodium and chloride changed insignificantly following nifedipine administration. The obtained results suggest that long-term nifedipine treatment of patients who were already given digoxin and furosemide neither improve nor worsen their clinical status.     

Planimetric and histological study of the aortae in atherosclerotic chickens treated with nifedipine,verapamil and diltiazem

Calcium appears to be involved in many of the cellular events which are thought to be important in atherogenesis. Calcium channel blockers have been shown to reduce arterial lipid accumulation in animals without altering serum cholesterol. Avian models of atherosclerosis offer economic and technical advantages over mammalian models. In this study, we examine the effects of nifedipine, verapamil and diltiazem at clinical and higher doses, on the extent of atherosclerosis of egg-fed chickens. In order to assess the extent of atherosclerosis quantitatively, the aortic lesions of the thoracic and abdominal aorta, aortic arch and supraaortic regions were measured by planimetry. Atherosclerotic lesions were evaluated histologically. Statistically significant reductions in the lipid deposition of the aorta were found in all the treated groups. The extent and distribution of atherosclerotic lesions were decreased in a significant way by verapamil, nifedipine and diltiazem. The higher the dosage used, the higher the regression of the atherosclerotic lesions. At clinical dosage, nifedipine showed the highest decrease of the lesions. In addition, the chicken atherosclerosis model has proved itself useful and very suitable for in vivo drug intervention studies.     

Effects of nifedipine,verapamil, and diltiazem on tip growth inFunaria hygrometrica

Protonemata ofFunaria hygrometrica Sibth. were treated with nifedipine, verapamil, or diltiazem. Responses to each of the drugs were, on the one hand, reduction of growth rate and tip cell length and, on the other hand, formation of apical swellings in caulonema tip cells and of anomalously oriented separation walls between main filaments and young side branches. The first effect is regarded as a more general expression of inhibition while the second complex of effects is attributed to perturbations in directed vesicle transport. Replacement of drug-containing media by normal Knop agar demonstrated the reversibility of inhibitor action: growth parameters were comparable to those of control protonemata within a few hours. A fast reaction, the formation of subapical vacoules, occurred within minutes of drug application and was only observed with verapamil and diltiazem. In connection with this process, rapid migrations of chloroplasts took place, but examination of the microtubule cytoskeleton in such cells by indirect immunofluorescence with a monoclonal antibody against tubulin showed an intact microtubule network. callose deposits in tip cells treated with verapamil. They were polarly distributed and started to appear in cell apices about 2h after the beginning of verapamil application. Two mechanisms of action for the tested inhibitors are discussed: (i) perturbations of membrane permeability by interference with one or more of the cell's Ca²⁺-transport systems, and (ii) a more indirect mechanism affecting vesicle transport via the microfilament system.     

Interactions of verapamil,D 600, flunarizine and nifedipine with cerebral histamine-receptors

Experiments conducted on membrane fractions of guinea-pig brain using ligand-binding techniques have shown that certain Ca²⁺-antagonists interact with histamine (H₁ or H₂) receptors. Flunarizine (inhibition constant, K_i ∼ 86 nM) was nearly as potent as diphenhydramine (K_i ∼ 44 nM) in inhibiting [³H]pyrilamine binding to cerebellar H₁-receptors, whereas verapamil, D 600 and nifedipine did not interact with this site. Regarding [³H]tiotidine binding to H₂-receptors of cerebral cortex, verapamil (K_i ∼ 1400 nM) and D 600 (K_i ∼ 1240 nM) were nearly as potent as cimetidine (K_i ∼ 910 nM) whereas flunarizine and nifedipine were inactive. The interaction of flunarizine with H₁-receptors might explain, in part, its sedative side-effect. The interaction of verapamil with H₂-receptors, demonstrated here for the first time, might be involved in the anti-arrhythmic action of this agent.     

Lack of melatonin response to acute administration of nifedipine and diltiazem in healthy men

Calcium antagonists have been shown to influence some endocrinological processes in mammals. The use of calcium channel blockers in clinical practice is well documented. The current study monitored nocturnal melatonin, prolactin, and cortisol levels in 19 healthy volunteers before and after administration of calcium channel blockers. The effect of nifedipine was tested in 9 subjects, while diltiazem was administered in 10 men. The nocturnal profile of the given parameters was studied between 23:00 and 05:00 h. At midnight (zero time), the participants were given placebo, nifedipine (in a sublingual dose of 20 mg) or diltiazem (in a single dose of 90 mg). The hypothesis that calcium channel blockers decrease nocturnal melatonin secretion has not been confirmed. The mean nocturnal levels of melatonin between 01:00 and 05:00 h were: 78.1+/-8.8 (control study) vs. 82.4+/-10.2 ng/l (nifedipine study) and 73.0+/-5.3 ng/l (control study) vs. 75.1+/-5.1 ng/l (diltiazem study). In conclusion, the calcium channel blockers used in this study do not alter the nocturnal melatonin secretory process in healthy men.     

Interactions between adenosine and nifedipine in the rat cerebral cortex

Nifedipine inhibits the uptake of [³H]adenosine into rat cerebral cortical synaptosomes with an IC₅₀ value of 1.1 μM. When applied by iontophoresis onto rat cerebral cortical neurons it potentiated the depressant effects of adenosine on spontaneous firing. Some of the calcium-antagonist actions of nifedipine may be mediated by adenosine.     

Comparison of nifedipine and diltiazem with salbutamol for prevention of preterm delivery in the ovariectomized, oestrogen-treated late pregnant rat

The ovariectomized, oestrogen-treated, late pregnant rat has been used to compare the ability of two calcium antagonists, diltiazem and nifedipine, with an agonist at beta-adrenoceptors, salbutamol, to prevent the development of uterine contractions, prolong gestation and maintain fetal survival in utero. Preterm delivery of the fetuses was not prevented in the animals infused with salbutamol (2 micrograms/kg/min), occurring at the same time, 30-40 h after ovariectomy, as in the saline-infused rats. The overall integral of uterine contractions was significantly reduced in the salbutamol-treated compared with the saline-treated animals due to decreased contractions after abortion. Both diltiazem (100 micrograms/kg/min) and nifedipine (3.1 and 6.2 micrograms/kg/min) produced significant inhibition of uterine contractions and in contrast to salbutamol prolonged gestation and improved fetal survival in utero as assessed at post mortem on Day 21. However, maternal survival was low (57%) with the higher dose of nifedipine, possibly reflecting the relaxant effect of this compound on vascular smooth muscle with consequent underperfusion of vital organs.     

Calcium channel blockers nifedipine and diltiazem inhibit Ca2+ release from intracellular stores in neutrophils.

We have undertaken a detailed study of the mechanisms of maintenance of intracellular Ca2+ homeostasis in human polymorphonuclear neutrophils (PMN) and its implications for phagocytosis and IgG Fc receptor (FcR) signaling. When PMN were incubated in Ca(2+)-free medium, cytoplasmic calcium concentration ([Ca2+]i) was markedly depressed and intracellular stores were depleted of calcium. [Ca2+]i in these depleted cells increased within 1 min when PMN were placed in medium containing Ca2+ and then decreased to a level close to the normal basal [Ca2+]i, replenishing the intracellular Ca2+ pools. LaCl3 prevented entry of Ca2+ into Ca(2+)-depleted PMN, but the calcium channel blockers nifedipine, diltiazem, and verapamil did not. Nifedipine and diltiazem but not verapamil inhibited the movement of Ca2+ from cytosol to intracellular stores. Nifedipine and diltiazem inhibited the normal increase in [Ca2+]i from aggregated IgG binding to FcR and also prevented formyl-methionyl-leucyl-phenyl-alanine (fMLP)-induced [Ca2+]i rise. Verapamil had no effect on either an fMLP- or IgG-mediated increase in [Ca2+]i. Consistent with this, nifedipine and diltiazem inhibited fMLP-stimulated phagocytosis (which is dependent on an increase in [Ca2+]i) when PMN had repleted intracellular stores. In contrast, LaCl3 inhibited fMLP-stimulated ingestion only in PMN which had intracellular store depleted. None of these compounds had any effect on phorbol dibutyrate-stimulated ingestion (which is independent of a [Ca2+]i rise). In summary, these data show that Ca2+ is in rapid equilibrium between intracellular and extracellular compartments in PMN. Exchange of cytoplasmic Ca2+ with the extracellular space is inhibited by LaCl3, while exchange of Ca2+ between the cytosol and intracellular stores is inhibited by the dihydropyridine nifedipine and the benzothiazepine diltiazem. These data suggest that these drugs, which are known to regulate some plasma membrane Ca2+ channels in excitable cells, can also regulate Ca2+ release from intracellular stores in PMN and that this regulation may have significant effects on PMN function.     

Intracellular calcium in the control of osteoclast function. I. Voltage-insensitivity and lack of effects of nifedipine, BAYK8644 and diltiazem.

We have recently demonstrated that in the rat osteoclast, a rise in the ambient calcium concentration induces a rapid elevation of cytosolic calcium, and that this phenomenon is accompanied by a complete inhibition of osteoclastic bone resorption. Here, we have attempted to characterise the electrophysiological nature of the putative 'calcium-activated' calcium channel. We have established that calcium influx into the osteoclast that occurs on exposure to elevated extracellular calcium is independent of membrane voltage and is insensitive to modulation by organic calcium channel modulators, namely nifedipine, BAYK8644 and diltiazem. The latter compounds were also unable to block the reduction of cell spread area and the inhibition of bone resorption produced in response to elevated extracellular calcium levels.